Fiaschetti Valeria, Ubaldi Nicolò, De Fazio Smeralda, Cossu Elsa
Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy.
European Hospital, 00149 Rome, Italy.
J Pers Med. 2022 Aug 25;12(9):1371. doi: 10.3390/jpm12091371.
Throughout this recent ongoing SARS-CoV-2 pandemic, the European Society of Breast Imaging have surely contributed in improving the management of unilateral axillary adenopathy appearance homolaterally to the side of vaccine inoculation. After considering the patient's COVID-19 history of vaccination, our group produced a day-to-day scheme that evaluates meticulously the probability of mammary malignancy, according to the lymph node characteristics including vascular abnormalities. It comprises of a UN (ultrasound node) score ranging from 2 to 5, that increases with the suspicion of malignancy. In this setting and in view of the additional incoming COVID-19 boost-dose vaccinations, we believe our model could be of great utility to radiologist when assessing patients whom do not have a straight forward diagnosis, in order to reduce breast cancer missed diagnosis, avoid delaying vaccinations, reduce rescheduling of breast imaging examinations and lastly avoid unnecessary lymph node biopsies.
在最近这场持续的新冠疫情期间，欧洲乳腺影像学会无疑为改善单侧腋窝淋巴结肿大（与疫苗接种侧同侧）的管理做出了贡献。在考虑患者的新冠疫苗接种史后，我们团队制定了一个每日方案，根据包括血管异常在内的淋巴结特征，细致评估乳腺恶性肿瘤的可能性。它包括一个从2到5的超声淋巴结（UN）评分，随着恶性肿瘤嫌疑性的增加而升高。在此背景下，鉴于即将到来的额外新冠加强针接种，我们认为我们的模型在评估诊断不明确的患者时，对放射科医生可能非常有用，以便减少乳腺癌漏诊、避免延迟疫苗接种、减少乳腺影像检查的重新安排，最后避免不必要的淋巴结活检。
